372 related articles for article (PubMed ID: 17371814)
1. Broad-spectrum antiviral activity of small interfering RNA targeting the conserved RNA termini of Lassa virus.
Müller S; Günther S
Antimicrob Agents Chemother; 2007 Jun; 51(6):2215-8. PubMed ID: 17371814
[TBL] [Abstract][Full Text] [Related]
2. Replicon system for Lassa virus.
Hass M; Gölnitz U; Müller S; Becker-Ziaja B; Günther S
J Virol; 2004 Dec; 78(24):13793-803. PubMed ID: 15564487
[TBL] [Abstract][Full Text] [Related]
3. Rapid identification of small interfering RNA that can effectively inhibit the replication of multiple influenza B virus strains.
Gao Y; Sun L; Dong J; Xu X; Shu Y; Chen M; Yin L; Liang Z; Jin Q
Antivir Ther; 2006; 11(4):431-8. PubMed ID: 16856616
[TBL] [Abstract][Full Text] [Related]
4. Sequence analysis of L RNA of Lassa virus.
Vieth S; Torda AE; Asper M; Schmitz H; Günther S
Virology; 2004 Jan; 318(1):153-68. PubMed ID: 14972544
[TBL] [Abstract][Full Text] [Related]
5. Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' End.
Djavani M; Lukashevich IS; Sanchez A; Nichol ST; Salvato MS
Virology; 1997 Sep; 235(2):414-8. PubMed ID: 9281522
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of West Nile virus replication in cells stably transfected with vector-based shRNA expression system.
Ong SP; Chu JJ; Ng ML
Virus Res; 2008 Aug; 135(2):292-7. PubMed ID: 18514349
[TBL] [Abstract][Full Text] [Related]
7. Sedimentation analysis of the RNAs isolated from interfering particles of Lassa and Machupo viruses.
Lukashevich IS; Trofimov NM; Golubev VP; Maryankova RF
Acta Virol; 1985 Dec; 29(6):455-60. PubMed ID: 2869655
[TBL] [Abstract][Full Text] [Related]
8. Effective siRNA targeting of the 3' untranslated region of the West Nile virus genome.
Anthony KG; Bai F; Krishnan MN; Fikrig E; Koski RA
Antiviral Res; 2009 Jun; 82(3):166-8. PubMed ID: 19135091
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production.
Aparicio O; Razquin N; Zaratiegui M; Narvaiza I; Fortes P
J Virol; 2006 Feb; 80(3):1376-84. PubMed ID: 16415015
[TBL] [Abstract][Full Text] [Related]
10. Identification and mapping of a region on the mRNA of Morbillivirus nucleoprotein susceptible to RNA interference.
Keita D; Servan de Almeida R; Libeau G; Albina E
Antiviral Res; 2008 Nov; 80(2):158-67. PubMed ID: 18634829
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus.
Asper M; Sternsdorf T; Hass M; Drosten C; Rhode A; Schmitz H; Günther S
J Virol; 2004 Mar; 78(6):3162-9. PubMed ID: 14990737
[TBL] [Abstract][Full Text] [Related]
12. RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene.
Vieth S; Drosten C; Lenz O; Vincent M; Omilabu S; Hass M; Becker-Ziaja B; ter Meulen J; Nichol ST; Schmitz H; Günther S
Trans R Soc Trop Med Hyg; 2007 Dec; 101(12):1253-64. PubMed ID: 17905372
[TBL] [Abstract][Full Text] [Related]
13. Expression of vector-based small interfering RNA against West Nile virus effectively inhibits virus replication.
Ong SP; Choo BG; Chu JJ; Ng ML
Antiviral Res; 2006 Dec; 72(3):216-23. PubMed ID: 16870272
[TBL] [Abstract][Full Text] [Related]
14. RNA interference of avian influenza virus H5N1 by inhibiting viral mRNA with siRNA expression plasmids.
Zhou K; He H; Wu Y; Duan M
J Biotechnol; 2008 Jun; 135(2):140-4. PubMed ID: 18456361
[TBL] [Abstract][Full Text] [Related]
15. Effective inhibition of infectious bursal disease virus replication in vitro by DNA vector-based RNA interference.
Gao Y; Liu W; Gao H; Qi X; Lin H; Wang X; Shen R
Antiviral Res; 2008 Aug; 79(2):87-94. PubMed ID: 18378010
[TBL] [Abstract][Full Text] [Related]
16. Insight into the binding modes of Lassa nucleoprotein complexed with ssRNA by molecular dynamic simulations and free energy calculations.
Zhang Y; Chen H; Han JG
J Biomol Struct Dyn; 2015; 33(5):946-60. PubMed ID: 24824824
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein.
Rodriguez-Carreno MP; Nelson MS; Botten J; Smith-Nixon K; Buchmeier MJ; Whitton JL
Virology; 2005 Apr; 335(1):87-98. PubMed ID: 15823608
[TBL] [Abstract][Full Text] [Related]
18. Positional effects and strand preference of RNA interference against hepatitis C virus target sequences.
Smith RM; Smolic R; Volarevic M; Wu GY
J Viral Hepat; 2007 Mar; 14(3):194-212. PubMed ID: 17305886
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin.
Kolokoltsov AA; Adhikary S; Garver J; Johnson L; Davey RA; Vela EM
Arch Virol; 2012 Jan; 157(1):121-7. PubMed ID: 21947546
[TBL] [Abstract][Full Text] [Related]
20. Suppression of hepatitis A virus genome translation and replication by siRNAs targeting the internal ribosomal entry site.
Kanda T; Zhang B; Kusov Y; Yokosuka O; Gauss-Müller V
Biochem Biophys Res Commun; 2005 May; 330(4):1217-23. PubMed ID: 15823573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
